Briakinumab
Briakinumab (ABT-874) is a human monoclonal antibody being developed by Abbott Laboratories for the treatment of rheumatoid arthritis, inflammatory bowel disease, and multiple sclerosis. As of 2011 drug development for psoriasis has been discontinued in the U.S. and Europe. Like ustekinumab, the antibody targets the interleukins 12 and 23.
Wikipage redirect
primaryTopic
Briakinumab
Briakinumab (ABT-874) is a human monoclonal antibody being developed by Abbott Laboratories for the treatment of rheumatoid arthritis, inflammatory bowel disease, and multiple sclerosis. As of 2011 drug development for psoriasis has been discontinued in the U.S. and Europe. Like ustekinumab, the antibody targets the interleukins 12 and 23.
has abstract
Briakinumab (ABT-874) est un a ...... é aux États-Unis et en Europe.
@fr
Briakinumab (ABT-874) is a hum ...... ts the interleukins 12 and 23.
@en
Briakinumab (ABT-874) ist ein ...... gsantrag wieder zurückgezogen.
@de
Il Briakinumab (o ABT-874) è u ...... Viene sviluppato dalla Abbott.
@it
برياكينوماب هو جسم مضاد وحيد ا ...... ي تأثيره على إنترلوكن 12 و 23.
@ar
CAS number
339308-60-0
FDA UNII code
978I8M0P8X
Wikipage page ID
25,230,853
page length (characters) of wiki page
Wikipage revision ID
991,684,467
Link from a Wikipage to another Wikipage
ATC prefix
L04
@en
ATC suffix
AC09
@en
bioavailability
N/A
@en
CAS number
ChemSpiderID
none
@en
legal status
investigational
@en
mab type
mab
@en
source
u
@en
target
IL-12 and IL-23
@en
type
mab
@en
Verifiedfields
changed
@en
verifiedrevid
459,982,272
Watchedfields
changed
@en
wikiPageUsesTemplate
hypernym
comment
Briakinumab (ABT-874) est un a ...... é aux États-Unis et en Europe.
@fr
Briakinumab (ABT-874) is a hum ...... ts the interleukins 12 and 23.
@en
Briakinumab (ABT-874) ist ein ...... gsantrag wieder zurückgezogen.
@de
Il Briakinumab (o ABT-874) è u ...... Viene sviluppato dalla Abbott.
@it
برياكينوماب هو جسم مضاد وحيد ا ...... ي تأثيره على إنترلوكن 12 و 23.
@ar
label
Briakinumab
@de
Briakinumab
@en
Briakinumab
@fr
Briakinumab
@it
برياكينوماب
@ar